Screener / SEC EDGAR /CIK 0001157601 /10-K filed Feb 19, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Madrigal Pharmaceuticals, Inc. MDGL

Compare with peers Embed
Who owns MDGL

Institutional owners are on their way

13F data can be up to 45 days old

We read every 13F filing after each quarter ends. The owners of MDGL show here after the next update.

Institutional ownership

Institutional owners

13F data sets, SEC

Institutional owners are on their wayWe read every 13F filing after each quarter ends. The owners of MDGL show here after the next update.

Funds that hold MDGL

Mutual funds and ETFs, each from its own latest portfolio report. Funds report on their own quarter ends.

Form N-PORT, SEC

Fund holdings are on their wayWe read the funds' N-PORT reports after each quarter. The funds that hold MDGL show here after the next update.

Superinvestors holding MDGL

The investors followed on Tickdelta, from their latest 13F.

All investors

None of the followed investors held MDGL in their latest 13F.

13D filings: owners who may push for change

Owners of more than 5%

Schedule 13D, last year
Nov 6, 2026 13D/A 10.0%of MDGL's shares
Baker Bros. Advisors LP and 3 more reporting persons · 2.33M shares · event Nov 6, 2026
Item 4, purpose of the transaction:Item 4 of Schedule 13D is supplemented and amended, as the case may be, as follows: This Amendment No. 5 is being filed to report the acquisition of common stock ("Common Stock") of Madrigal Pharmaceuticals, Inc. (the "Issuer") reported in Item 5(c) that resulted in a more than 1 percent change in beneficial ownership. The disclosure regarding the purchases in Item 5(c) below is incorporated herein by reference. The Funds hold securities of the Issuer for investment purposes. The Reporting Persons or their affiliates may purchase additional securities or dispose of securities in varying amounts and at varying times depending upon the Reporting Persons' continuing assessments of pertinent f…
Read the filing
Dec 12, 2025 13D/A 7.8%of MDGL's shares
Rebecca Taub, M.D. · 1.81M shares · event Dec 10, 2025
Item 4, purpose of the transaction:No changes, except that the Reporting Person no longer serves as Chief Medical Officer of the Issuer; the Reporting Person serves as Senior Scientific and Medical Advisor of the Issuer and continues to serve as a member of the Board of Directors of the Issuer.
Read the filing
Dec 12, 2025 13D/A 7.8%of MDGL's shares
Paul A Friedman, M.D. · 1.81M shares · event Dec 10, 2025
Item 4, purpose of the transaction:No changes, except that the Reporting Person no longer serves as Chairman of the Board and Chief Executive Officer of the Issuer; the Reporting Person continues to serve as a member of the Board of Directors of the Issuer.
Read the filing

Sources

SEC's Form 13F data sets, each quarter; Form N-PORT data sets for the funds; Schedule 13D filings.

Also

Investors: the portfolios of the superinvestors followed here. Insider trades: what the company's own people bought and sold.

Work with it

Excel workbook · CSV

Next:Cash & buybacks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.